Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by bfwon Jul 13, 2017 10:53am

215 Views

Post# 26464612

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Luc does it again

Here was the clown back in November :)

Notably, his posts were surrounded by excellent research by the rest of the board.

bfw

houbahop wrote:
Yaaahh!
Luc has sucked another big fish in another one of Thera's almost worthless product!

Ibalizumal may be breaking through, but how many will consume it?
A few hundreds? a couple of thousands?
Another super costly to develop product with very few buyers...